Carbamazepine-Erythromycin Interaction: Case Studies and Clinical Significance

JAMA: The Journal of the American Medical Association

Volumn 255, Issue 9, 1986, Pages 1165-1167

  Wroblewski, Bruno A ^a   Singer, William D ^a,b,c   Whyte, John ^a,d  

^a Departments of Clinical Pharmacy Greenery Rehabilitation and Skilled Nursing Center ^*  (United States)

^b Departments of Pediatrics ^*  (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; ERYTHROMYCIN; PHENOBARBITAL;

ADVERSE DRUG REACTION; ATAXIA; CASE REPORT; CENTRAL NERVOUS SYSTEM; CONVULSION; DRUG BLOOD LEVEL; DRUG INTERACTION; DRUG MONITORING; DRUG THERAPY; HUMAN; INTOXICATION; LETHARGY; NERVOUS SYSTEM; NEUROTOXICITY; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PRIORITY JOURNAL; SOMNOLENCE; THERAPY;

ADULT; CARBAMAZEPINE; CASE REPORT; DRUG INTERACTIONS; ERYTHROMYCIN; FEMALE; FLUORESCENCE POLARIZATION; HUMAN; MALE;

EID: 0022642814     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1986.03370090087026     Document Type: Article

References (11)

1. Dravet C, Mesdjian E, Cenraud B, et al.: Interaction between carbamazepine and triacetyloleandomycin. Lancet 1977;1:810-811.
2. Mesdjian E, Dravet C, Cenraud B, et al.: Carbamazepine intoxication due to triacetyloleandomycin administration in epileptic patients. Epilepsia 1980;21:489-496.
3. Wong YY, Ludden TM, Bell RD: Effect of erythromycin on carbamazepine kinetics. Clin Pharmacol Ther 1983;33:460-464.
4. Straughn J: Erythromycin-carbamazepine interaction? S Afr Med J 1982;20:420-421.
5. Hedrick R, Williams F, Morin R, et al.: Carbamazepine-erythromycin interaction leading to carbamazepine toxicity in four epileptic children. Ther Drug Monit 1983;5:405-407.
6. Carranco E, Kareus J, Co S, et al.: Carbamazepine toxicity induced by concurrent erythromycin therapy. Arch Neurol 1985;42:187-188.
7. Tokola RA, Neuvonen PJ: Pharmacokinetics of antiepileptic drugs. Acta Neurol Scand 1983; 68(suppl 97):17-27.
8. Rapeport WG: Factors influencing the relationship between carbamazepine plasma concentration and its clinical effects in patients with epilepsy. Clin Neuropharmacol 1985;8:141-149.
9. Hemsworth TE, Renton KW: Depression of theophylline metabolism and elimination by troleandomycin and erythromycin. Biochem Pharmacol 1981;30:1299-1304.
10. Renton KW, Gray JD, Hung OR: Depression of theophylline elimination by erythromycin. Clin Pharmacol Ther 1981;30:422-426.
11. Ashton MD, Ball SG, Thomas TH, et al.: Water intoxication associated with carbamazepine treatment. Br Med J 1977;30:1134-1135.